Atlanta Center for Medical Research   Report issue

For profit Phase 1 Phase 2
Founded: Atlanta GA United States (1982)

Organization Overview

First Clinical Trial
2007
NCT00555412
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 1)

Bipolar Disorder (Phase 1)

Compulsive Personality Disorder (Phase 2)

Disease (Phase 2)

Obsessive-Compulsive Disorder (Phase 2)

Psychotic Disorders (Phase 2)

Schizophrenia (Phase 2)

Weight Gain (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 7